Construction of a nomogram predictive model for thermal ablation efficacy in benign thyroid nodules based on multimodal ultrasound and serological markers.

BACKGROUND: This study aimed to develop a nomogram for predicting the 1-year volume reduction ratio (VRR) of the ablated area after thermal ablation of benign thyroid nodules (BTN) based on preoperative clinical, ultrasound, and serological features, and to explore the role of the ablation volume ratio (AVR). METHODS: This retrospective study included 243 BTN patients who underwent ultrasound-guided radiofrequency or microwave ablation between January 2020 and December 2024. Clinical, ultrasound, serological, and procedural data were collected. Contrast-enhanced ultrasound was performed immediately after ablation to assess the ablation zone and calculate AVR. Patients were followed at 1, 3, 6, and 12 months and classified as favorable (VRR ≥80%) or unfavorable. The cohort was randomly divided into training (70%) and validation (30%) sets. Logistic regression identified independent predictors, and a nomogram was constructed and evaluated using ROC, calibration, and decision curve analyses. AVR was higher in the favorable group but was not an independent predictor. Multivariate analysis identified BMI, maximum diameter, FT3, morphology, vascularity, and dangerous triangle location as independent predictors. The model showed good performance (AUC 0.904 training, 0.815 validation). CONCLUSION: A nomogram based on preoperative factors provides a noninvasive tool for predicting 1-year outcomes after BTN ablation. AVR reflects procedural adequacy but has limited prognostic value. Further multicenter validation is needed.